Loeb Partners Has Cut Cvs Health (CVS) Stake By $811,200, Man SE (ETR:MAN) Covered By 0 Bulls

June 20, 2017 - By Migdalia James

Loeb Partners Corporation decreased Cvs Health Corp (CVS) stake by 50.73% reported in 2016Q4 SEC filing. Loeb Partners Corporation sold 10,400 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Loeb Partners Corporation holds 10,100 shares with $797,000 value, down from 20,500 last quarter. Cvs Health Corp now has $76.56B valuation. The stock increased 1.35% or $1.04 during the last trading session, reaching $78.1. About shares traded. CVS Health Corp (NYSE:CVS) has declined 24.40% since June 20, 2016 and is downtrending. It has underperformed by 41.10% the S&P500.

Among 5 analysts covering MAN (ETR:MAN), 0 have Buy rating, 2 Sell and 3 Hold. Therefore 0 are positive. MAN had 8 analyst reports since July 28, 2015 according to SRatingsIntel. The company was maintained on Friday, September 11 by Landesbank. The stock of Man SE (ETR:MAN) has “Hold” rating given on Tuesday, November 3 by Landesbank. The firm has “Hold” rating given on Wednesday, July 29 by Warburg Research. The firm has “Hold” rating given on Tuesday, July 28 by Commerzbank. As per Wednesday, July 29, the company rating was downgraded by Independent Research. As per Thursday, October 29, the company rating was downgraded by Independent Research. Warburg Research maintained the shares of MAN in report on Thursday, October 29 with “Hold” rating. S&P Research downgraded the stock to “Sell” rating in Wednesday, October 28 report. See Man SE (ETR:MAN) latest ratings:

Since February 2, 2017, it had 0 insider purchases, and 8 insider sales for $25.10 million activity. Another trade for 1,500 shares valued at $145,407 was sold by BUCHBAND RICHARD. GREEN DARRYL sold $6.09M worth of Man SE (ETR:MAN) on Friday, February 3. The insider SWAN MARA E sold 24,380 shares worth $2.37 million. CHANDRASHEKAR SRIRAM sold $2.33M worth of Man SE (ETR:MAN) on Thursday, February 16. $6.31 million worth of Man SE (ETR:MAN) shares were sold by PRISING JONAS. 77,029 shares were sold by VAN HANDEL MICHAEL J, worth $7.49 million on Thursday, February 2.

About 4,075 shares traded. Man SE (ETR:MAN) has risen 32.35% since June 20, 2016 and is uptrending. It has outperformed by 15.65% the S&P500.

MAN SE is a German manufacturer of commercial vehicles, engines and mechanical engineering equipment. The company has market cap of 13.94 billion EUR. The Firm is active within two business areas, which are divided into four main divisions: Commercial Vehicles business area consists of the division MAN Truck & Bus as well as MAN Latin America; and Power Engineering business area includes MAN Diesel & Turbo as well as Renk division. It currently has negative earnings. MAN Truck & Bus produces trucks ranging from 7.5 to 44 tons and buses for scheduled services through to luxury travel.

Investors sentiment increased to 0.91 in Q4 2016. Its up 0.10, from 0.81 in 2016Q3. It increased, as 37 investors sold Man SE shares while 144 reduced holdings. 53 funds opened positions while 111 raised stakes. 58.59 million shares or 1.88% less from 59.71 million shares in 2016Q3 were reported. Comerica National Bank & Trust, a Michigan-based fund reported 50,649 shares. State Of Tennessee Treasury Department owns 0.07% invested in Man SE (ETR:MAN) for 146,688 shares. Everpoint Asset Mgmt Llc has 724,661 shares. Ontario – Canada-based Canada Pension Plan Investment Board has invested 0.1% in Man SE (ETR:MAN). Assetmark reported 218 shares. Sumitomo Mitsui Trust Holdings has invested 0.03% in Man SE (ETR:MAN). 1.34 million are owned by Fiduciary Management Wi. Moreover, Huntington Bancorp has 0% invested in Man SE (ETR:MAN) for 560 shares. Ahl Llp reported 98,862 shares. Millennium Ltd Liability Com reported 0.04% of its portfolio in Man SE (ETR:MAN). Moreover, Delta Lloyd Nv has 0.06% invested in Man SE (ETR:MAN). Gsa Llp reported 6,661 shares. Brant Point Inv Mngmt Ltd Liability Corp has 0.49% invested in Man SE (ETR:MAN). Blackrock Inc holds 612,629 shares. United Capital Finance Advisers Ltd holds 0.01% or 9,080 shares.

Among 17 analysts covering CVS Health (NYSE:CVS), 10 have Buy rating, 0 Sell and 7 Hold. Therefore 59% are positive. CVS Health had 27 analyst reports since July 22, 2015 according to SRatingsIntel. The company was maintained on Thursday, December 17 by Oppenheimer. The stock of CVS Health Corp (NYSE:CVS) earned “Hold” rating by Jefferies on Monday, December 12. RBC Capital Markets maintained CVS Health Corp (NYSE:CVS) rating on Wednesday, August 5. RBC Capital Markets has “Outperform” rating and $132 target. The firm has “Strong Buy” rating given on Monday, November 2 by S&P Research. On Monday, June 20 the stock rating was downgraded by Morgan Stanley to “Equal-Weight”. The stock has “Overweight” rating by Barclays Capital on Friday, December 18. The stock of CVS Health Corp (NYSE:CVS) earned “Buy” rating by Tigress Financial on Friday, April 28. Oppenheimer maintained CVS Health Corp (NYSE:CVS) rating on Monday, November 2. Oppenheimer has “Outperform” rating and $115 target. The stock has “Buy” rating by UBS on Thursday, October 6. The stock has “Neutral” rating by Citigroup on Monday, May 9.

Loeb Partners Corporation increased Chevron Corp New (NYSE:CVX) stake by 3,950 shares to 29,150 valued at $3.43M in 2016Q4. It also upped Amgen Inc (NASDAQ:AMGN) stake by 5,200 shares and now owns 7,800 shares. Monmouth Real Estate Invt Co (NYSE:MNR) was raised too.

Investors sentiment decreased to 0.74 in Q4 2016. Its down 0.24, from 0.98 in 2016Q3. It worsened, as 135 investors sold CVS shares while 627 reduced holdings. 127 funds opened positions while 440 raised stakes. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Citizens And Northern reported 24,049 shares stake. Tru Co Of Virginia Va invested in 90,507 shares or 1.16% of the stock. Rfg Advisory Group Ltd Llc stated it has 0.17% in CVS Health Corp (NYSE:CVS). Veritas Investment Mgmt Llp reported 7.78% in CVS Health Corp (NYSE:CVS). Edge Asset Mngmt has 0.19% invested in CVS Health Corp (NYSE:CVS). General Investors invested in 1.57% or 197,280 shares. Mirae Asset Global Invests Ltd holds 0.08% or 43,252 shares in its portfolio. Howe And Rusling Inc has invested 0.03% in CVS Health Corp (NYSE:CVS). Cwm Limited Liability Com stated it has 0% in CVS Health Corp (NYSE:CVS). North Carolina-based Hamilton Point Investment Advsrs Lc has invested 1.78% in CVS Health Corp (NYSE:CVS). Peak6 Invests Limited Partnership reported 0.06% stake. Anchor Capital Ltd Liability stated it has 0.72% in CVS Health Corp (NYSE:CVS). Boston Common Asset Management Limited Liability Corporation accumulated 0.8% or 69,137 shares. The Minnesota-based Compass Management Inc has invested 3.99% in CVS Health Corp (NYSE:CVS). Florida-based Provise Mgmt Gru Lc has invested 0.35% in CVS Health Corp (NYSE:CVS).

Since February 1, 2017, it had 0 insider buys, and 7 insider sales for $40.53 million activity. The insider Denton David M sold 230,510 shares worth $18.44M. The insider Boratto Eva C sold $479,908. MERLO LARRY J had sold 76,494 shares worth $5.99M. The insider Roberts Jonathan C sold 61,196 shares worth $4.90 million. Sussman Andrew also sold $1.13 million worth of CVS Health Corp (NYSE:CVS) shares. Shares for $1.88M were sold by Brennan Troyen A on Tuesday, March 21.

Analysts await CVS Health Corp (NYSE:CVS) to report earnings on August, 1. They expect $1.31 earnings per share, down 0.76% or $0.01 from last year’s $1.32 per share. CVS’s profit will be $1.28B for 14.90 P/E if the $1.31 EPS becomes a reality. After $1.17 actual earnings per share reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 11.97% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: